贝叶斯重新分析在临床研究中的作用
Josep M García-Alamino1, M López-Cano2
1Global Health, Gender and Society (GHenderS), Facultat de Ciències de la Salut, Blanquerna-Universitat Ramón Llull, Barcelona, Spain.
World journal of surgery
|March 19, 2025
概括
对大型语言模型辅助诊断的贝叶斯式再分析表明,先前的假设显著影响了结论. 这项研究强调了不同的先验如何导致对诊断益处的证据对立的解释.
科学领域:
- 医疗信息学 医疗信息学
- 统计建模 统计建模
- 医疗保健中的人工智能
背景情况:
- 大型语言模型 (LLM) 在协助医学诊断方面显示出潜力.
- 对LLM辅助诊断的证据的解释需要严格的统计评估.
- 贝叶斯分析为基于新证据的信念更新提供了一个框架.
研究的目的:
- 用贝叶斯方法重新分析LLM辅助诊断的证据.
- 调查先前假设对从诊断研究中得出的结论的影响.
- 评估贝叶斯分析是否揭示了支持或反对LLM辅助诊断的强有力的证据.
主要方法:
- 贝叶斯对现有诊断研究数据的重新分析.
- 探索不同的先前概率分布,代表不同程度的初始信念.
- 根据不同的先前假设和观察到的数据,对后期概率的评估.
主要成果:
- 前期假设的选择极大地影响了后期获益的概率.
- 一些先前的假设导致没有证据的结论,而另一些则表明有强有力的证据证明了益处.
- 观察到的研究结果,当与不同的先验相结合时,产生了不同的结论.
结论:
- 贝叶斯分析对评估LLM辅助诊断时的先前规范敏感.
- 如果不仔细考虑先例,关于LLM诊断益处的结论可能会误导.
- 进一步的研究应侧重于在临床AI评估中选择适当的先验的可靠方法.
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
110
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
110
Biostatistics: Overview
214
Biostatistics plays a crucial role in understanding and analyzing data in healthcare and biology. Biostatisticians conduct experiments, gather evidence, and draw meaningful conclusions using statistical methods and techniques. Different variables form the foundation of biostatistical analysis, allowing researchers to understand and interpret data effectively. These variables are classified into different types, each serving a specific purpose in statistical analysis.
Discrete variables are...
Discrete variables are...
214
Comparing the Survival Analysis of Two or More Groups
113
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
113
Statistical Software for Data Analysis and Clinical Trials
475
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
475
Regression Toward the Mean
6.3K
Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
6.3K
Kaplan-Meier Approach
74
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
74


